...
首页> 外文期刊>Atherosclerosis >Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis.
【24h】

Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis.

机译:他汀类药物治疗的糖尿病和非糖尿病冠心病患者中预测心血管事件的因素。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: We aimed at identifying which lipid factors drive vascular risk in statin-treated patients with coronary artery disease (CAD). METHODS: We recorded vascular events over 5.6 years in 491 consecutive statin-treated patients with angiographically proven stable CAD, covering 2750 patient-years. RESULTS: In the total population, low high-density lipoprotein (HDL) cholesterol (standardized adjusted HR 0.73 [0.60-0.89]; p=0.001), low apolipoprotein A1 (0.77 [0.65-0.92]; p=0.003), a small low-density lipoprotein (LDL) particle diameter (0.76 [0.64-0.91]; p=0.002), and high triglycerides (1.20 [1.05-1.38]; p=0.007) predicted vascular events, but not total cholesterol, LDL cholesterol, or apolipoprotein B. Factor analysis in the lipid profiles of our patients revealed an HDL-related factor and an LDL-related factor. Concordant with the results for individual lipid parameters, the HDL-related factor (0.69 [0.58-0.83]; p<0.001) but not the LDL-related factor (p=0.455) predicted vascular events. Patients with type 2 diabetes (T2DM; n=116) were at a higher vascular risk than non-diabetic subjects (38.6% vs. 24.1%; p<0.001), and like in the total population the HDL-related factor (0.59 [0.44-0.77]; p<0.001) but not the LDL-related factor (p=0.591) predicted vascular risk in diabetic patients. CONCLUSIONS: The pattern of low HDL cholesterol, low apolipoprotein A1, small LDL particles, and high triglycerides drives vascular risk in statin-treated coronary patients, particularly in those with T2DM.
机译:目的:我们的目的是确定哪些类脂因子会导致他汀类药物治疗的冠心病(CAD)患者的血管危险。方法:我们记录了491例接受他汀类药物治疗且经血管造影证实为稳定CAD的连续患者,历时5.6年,覆盖2750病人-年。结果:在总人群中,低高密度脂蛋白(HDL)胆固醇(标准校正后HR 0.73 [0.60-0.89]; p = 0.001),低载脂蛋白A1(0.77 [0.65-0.92]; p = 0.003),小低密度脂蛋白(LDL)粒径(0.76 [0.64-0.91]; p = 0.002)和高甘油三酸酯(1.20 [1.05-1.38]; p = 0.007)预测血管事件,但不能预测总胆固醇,LDL胆固醇或载脂蛋白B。我们患者血脂谱中的因子分析显示了HDL相关因子和LDL相关因子。与各个脂质参数的结果一致,HDL相关因子(0.69 [0.58-0.83]; p <0.001)而非LDL相关因子(p = 0.455)预测了血管事件。 2型糖尿病(T2DM; n = 116)患者的血管风险高于非糖尿病患者(38.6%vs. 24.1%; p <0.001),与总人群中HDL相关因子(0.59 [ 0.44-0.77]; p <0.001),但不是LDL相关因子(p = 0.591)预测糖尿病患者的血管风险。结论:低HDL胆固醇,低载脂蛋白A1,低LDL颗粒和高甘油三酸酯的模式在他汀类药物治疗的冠心病患者中尤其是在患有T2DM的冠心病患者中驱动血管风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号